Skip to main content
Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
5.53
+0.04 (0.73%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Valneva SE Revenue

In the year 2025, Valneva SE had annual revenue of 174.66M EUR with 3.00% growth. Valneva SE had revenue of 47.69M in the quarter ending December 31, 2025, a decrease of -9.92%.

Revenue (ttm)
174.66M EUR
Revenue Growth
+3.00%
P/S Ratio
2.40
Revenue / Employee
259,138 EUR
Employees
674
Market Cap
491.15M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025174.66M5.08M3.00%
Dec 31, 2024169.58M15.87M10.32%
Dec 31, 2023153.71M-207.59M-57.46%
Dec 31, 2022361.30M13.22M3.80%
Dec 31, 2021348.09M237.76M215.52%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
REGENXBIO 170.44M
Ginkgo Bioworks Holdings 170.16M
4D Molecular Therapeutics 85.21M
XOMA Royalty 52.15M
Entrada Therapeutics 25.42M
Prelude Therapeutics 12.14M
Armata Pharmaceuticals 4.90M
Revenue Rankings

VALN News

More News